pharmalittle

Pharmalot By Ed Silverman

Pharmalittle: Biogen defends its controversial Alzheimer’s drug; critics pan Pfizer plan for Covid-19 shot production in Africa

Pharmalot By Ed Silverman

Pharmalittle: Pfizer cuts deal for Covid-19 shot to be partially made in South Africa; wholesalers to pay $1.1b to NY to settle opioid suit

Pharmalot By Ed Silverman

Pharmalittle: Pfizer seeks full FDA approval for its Covid-19 vaccine; CT attorney general calls some Sacklers ‘entitled thugs’

Pharmalot By Ed Silverman

Pharmalittle: Lilly seeks speedy U.S. approval for its Alzheimer’s drug; FDA’s Woodcock ‘not concerned’ about criticism

Pharmalot By Elizabeth Cooney

Pharmalittle: Inside the FDA’s contentious Aduhelm approval; Peter Bach heading to liquid biopsy startup

Pharmalot By Ed Silverman

Pharmalittle: AstraZeneca may have used ‘outdated’ info about its Covid-19 shot; Democrats eye drug-pricing measures

Pharmalot By Ed Silverman

Pharmalittle: U.S. sits on millions of AstraZeneca vaccine doses; WTO again fails to act on Covid-19 proposal

Pharmalot By Ed Silverman

Pharmalittle: Covid-19 forces FDA to postpone inspections; pharma urges Biden to reject WTO proposal

Pharmalot By Ed Silverman

Pharmalittle: Merck says early data shows pill is effective against Covid-19; WHO’s COVAX program ships first doses

Pharmalot By Damian Garde

Pharmalittle: Sarepta wins another FDA nod; Germans balk at AstraZeneca vaccine

Pharmalot By Ed Silverman

Pharmalittle: House Dems slip drug pricing proposal into Covid-19 relief bill; FDA grants emergency use for Lilly drug

Pharmalot By Ed Silverman

Pharmalittle: FDA finds Moderna vaccine effective; Trump drug discount card gets new life

Pharmalot By Damian Garde

Pharmalittle: Operation Warp Speed is more Army than science; J&J’s Covid-19 vaccine moves forward

Pharmalot By Ed Silverman

Pharmalittle: In political ploy, Trump promises drug coupons to seniors; N.Y. plans its own Covid-19 vaccine reviews

Pharmalot By Ed Silverman

Pharmalittle: Trump may not approve FDA emergency use guidelines; U.K. starts world’s first Covid-19 challenge trial

Pharmalot By Elizabeth Cooney

Pharmalittle: Slaoui vows to quit OWS if politics trumps vaccine science; do we have enough freezers?

Pharmalot By Damian Garde

Pharmalittle: Trump promises a Covid-19 vaccine in 2020; WHO’s grand experiment is faltering

Pharmalot By Ed Silverman

Pharmalittle: Lilly starts late-stage trial of Covid-19 antibody; concern grows over political intervention on Covid-19 vaccine

Pharmalot By Ed Silverman

Pharmalittle: Trump officials maintain Covid-19 vaccine won’t be influenced by politics; Novartis pays $678 million to settle kickback charges

Pharmalot By Ed Silverman

Pharmalittle: Groups backed by pharma oppose equitable Covid-19 pricing; AstraZeneca strikes big Covid-19 vaccine deal

Pharmalot By Ed Silverman

Pharmalittle: France piles pressure on Sanofi over Covid-19 vaccine; GOP fails to land a punch on Bright

Pharmalot By Ed Silverman

Pharmalittle: Thousands sign up for trials studying hydroxycholoroquine; Gilead drug fails to help Covid-19 patients

Pharmalot By Ed Silverman

Pharmalittle: Novartis to test hydroxycholoroquine in Covid-19; malaria drug failed to protect lupus patients from coronavirus

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalittle: Early data suggests Gilead Covid-19 drug works; did FDA drop standards too far in hunt for chloroquine?